Notice of Kidney Interagency Coordinating Committee Meeting, 43757 [2014-17685]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 144 / Monday, July 28, 2014 / Notices
Contact Person: Ernest W Lyons, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS/Neuroscience Center,
6001 Executive Boulevard, Suite 3208, MSC
9529, Bethesda, MD 20892–9529, 301–496–
4056, lyonse@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: July 22, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–17676 Filed 7–25–14; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Central
Repositories Non Renewable Sample Access
Review-PAR11–306-Kidney Diseases,
Diabetes and HCC.
Date: August 28, 2014.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, Niddk, National Institutes Of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
17:53 Jul 25, 2014
Dated: July 22, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–17675 Filed 7–25–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Kidney Interagency
Coordinating Committee Meeting
The Kidney Interagency
Coordinating Committee (KICC) will
hold a meeting on September 12, 2014
about assessing public health
interventions in chronic kidney disease
(CKD). The meeting is open to the
public.
DATES: The meeting will be held on
September 12, 2014, 9 a.m. to 12 p.m.
Individuals wanting to present oral
comments must notify the contact
person at least 10 days before the
meeting date.
ADDRESSES: The meeting will be held in
Building 31 on the NIH Campus at 9000
Rockville Pike, Bethesda, MD 20894.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
meeting, contact Dr. Andrew S. Narva,
Executive Secretary of the Kidney
Interagency Coordinating Committee,
National Institute of Diabetes and
Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room
9A27, MSC 2560, Bethesda, MD 20892–
2560, telephone: 301–594–8864; FAX:
301–480–0243; email: nkdep@
info.niddk.nih.gov.
SUPPLEMENTARY INFORMATION: The KICC,
chaired by the National Institute of
Diabetes and Digestive and Kidney
Diseases (NIDDK), comprises members
of the Department of Health and Human
Services and other Federal agencies that
support kidney-related activities,
facilitates cooperation, communication,
and collaboration on kidney disease
among government entities. KICC
meetings, held twice a year, provide an
opportunity for Committee members to
learn about and discuss current and
future kidney programs in KICC member
organizations and to identify
opportunities for collaboration. The
September 12, 2014 KICC meeting will
focus on assessing public health
interventions in CKD.
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
SUMMARY:
BILLING CODE 4140–01–P
VerDate Mar<15>2010
and Hematology Research, National Institutes
of Health, HHS)
Jkt 232001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
43757
person listed on this notice at least 10
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future KICC meetings should send a
request to nkdep@info.niddk.nih.gov.
Dated: July 10, 2014.
Camille M. Hoover,
Executive Officer, National Institute of
Diabetes and Digestive and Kidney Diseases,
National Institutes of Health.
[FR Doc. 2014–17685 Filed 7–25–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIH
Pain Consortium Centers of Excellence in
Pain Education (4422).
Date: August 4–5, 2014.
Time: 9:00 a.m. to 6:00 p.m.
E:\FR\FM\28JYN1.SGM
28JYN1
]]>Agencies
[Federal Register Volume 79, Number 144 (Monday, July 28, 2014)]
[Notices]
[Page 43757]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-17685]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Kidney Interagency Coordinating Committee Meeting
SUMMARY: The Kidney Interagency Coordinating Committee (KICC) will hold
a meeting on September 12, 2014 about assessing public health
interventions in chronic kidney disease (CKD). The meeting is open to
the public.
DATES: The meeting will be held on September 12, 2014, 9 a.m. to 12
p.m. Individuals wanting to present oral comments must notify the
contact person at least 10 days before the meeting date.
ADDRESSES: The meeting will be held in Building 31 on the NIH Campus at
9000 Rockville Pike, Bethesda, MD 20894.
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, contact Dr. Andrew S. Narva, Executive Secretary of the
Kidney Interagency Coordinating Committee, National Institute of
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building
31A, Room 9A27, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-594-
8864; FAX: 301-480-0243; email: nkdep@info.niddk.nih.gov.
SUPPLEMENTARY INFORMATION: The KICC, chaired by the National Institute
of Diabetes and Digestive and Kidney Diseases (NIDDK), comprises
members of the Department of Health and Human Services and other
Federal agencies that support kidney-related activities, facilitates
cooperation, communication, and collaboration on kidney disease among
government entities. KICC meetings, held twice a year, provide an
opportunity for Committee members to learn about and discuss current
and future kidney programs in KICC member organizations and to identify
opportunities for collaboration. The September 12, 2014 KICC meeting
will focus on assessing public health interventions in CKD.
Any member of the public interested in presenting oral comments to
the Committee should notify the contact person listed on this notice at
least 10 days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present; oral
comments and presentations will be limited to a maximum of 5 minutes.
Printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
Committee by forwarding their statement to the contact person listed on
this notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person. Because of time constraints for the meeting,
oral comments will be allowed on a first-come, first-serve basis.
Members of the public who would like to receive email notification
about future KICC meetings should send a request to
nkdep@info.niddk.nih.gov.
Dated: July 10, 2014.
Camille M. Hoover,
Executive Officer, National Institute of Diabetes and Digestive and
Kidney Diseases, National Institutes of Health.
[FR Doc. 2014-17685 Filed 7-25-14; 8:45 am]
BILLING CODE 4140-01-P
